Coherus BioSciences Inc (CHRS)
2.025
+0.10
(+4.92%)
USD |
NASDAQ |
Apr 26, 12:39
Coherus BioSciences Cash from Investing (TTM): 144.64M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 144.64M |
| September 30, 2023 | -20.46M |
| June 30, 2023 | -71.46M |
| March 31, 2023 | -113.71M |
| December 31, 2022 | -166.85M |
| September 30, 2022 | 70.54M |
| June 30, 2022 | 86.98M |
| March 31, 2022 | 111.45M |
| December 31, 2021 | -138.41M |
| September 30, 2021 | -35.84M |
| June 30, 2021 | -35.43M |
| March 31, 2021 | -298.26M |
| December 31, 2020 | -14.40M |
| September 30, 2020 | -230.52M |
| June 30, 2020 | -247.22M |
| March 31, 2020 | 0.851M |
| December 31, 2019 | -12.73M |
| September 30, 2019 | 9.116M |
| June 30, 2019 | 22.22M |
| Date | Value |
|---|---|
| March 31, 2019 | -3.206M |
| December 31, 2018 | -1.188M |
| September 30, 2018 | -2.583M |
| June 30, 2018 | 13.31M |
| March 31, 2018 | 33.98M |
| December 31, 2017 | -4.417M |
| September 30, 2017 | -22.37M |
| June 30, 2017 | -51.58M |
| March 31, 2017 | -55.94M |
| December 31, 2016 | -6.515M |
| September 30, 2016 | -4.393M |
| June 30, 2016 | -7.077M |
| March 31, 2016 | -7.784M |
| December 31, 2015 | -6.949M |
| September 30, 2015 | -6.004M |
| June 30, 2015 | -3.627M |
| March 31, 2015 | -3.912M |
| December 31, 2014 | -0.525M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-298.26M
Minimum
Mar 2021
144.64M
Maximum
Dec 2023
-49.45M
Average
-20.46M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| AbbVie Inc | -2.009B |
| Inovio Pharmaceuticals Inc | 87.36M |
| Nektar Therapeutics | 139.56M |
| Avid Bioservices Inc | -51.17M |
| Stereotaxis Inc | 19.76M |